Get the App

Back Stocks profile

Stock analysis tool for investors

Apollo Hospitals Enterprise Ltd.

NSE: APOLLOHOSP | BSE:508869

₹6258.60 -125.50 (-1.97%) 1D

Diversified Consumer Services

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

6251.00

Today’s High

6380.00

52W low

4365.00

52W High

6874.40

Open Price

6380.00

Prev. Close

6023.1500

Volume

268172.00

Value

1678381279.20

Fundamentals

Market Cap Cr

89989.10

Price to Earnings

114.00

Price to Book Value

13.80

Dividend Yield

0.20

PE to Growth

35.40

Op Revenue TTM Cr

18417.50

Net Profit TTM Cr

789.32

Cash From Operating Activity Cr

1376.70

Return on Equity %

13.21

EMA & SMA

Bullish Moving Averages

6

Bearish Moving Averages

10

5Day EMA

6279.7

10Day EMA

6283.8

12Day EMA

6286.6

20Day EMA

6291.4

26Day EMA

6290.5

50Day EMA

6249.8

100Day EMA

6059.2

200Day EMA

5697.4

5Day SMA

6271.9

10Day SMA

6264.8

20Day SMA

6331.4

30Day SMA

6269.8

50Day SMA

6336.1

100Day SMA

6095.8

150Day SMA

5771.4

200Day SMA

5587.5

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

26 Apr, 2024

51.1

Week

46.7

Month

44.8

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

6296.55

PIVOT

First Resistance

6342.05

Second Resistance

6425.50

Third Resistance

6471.00

First Support

6213.10

Second Support

6167.60

Third Support

6084.15

Relative Strength Index

48.66

Money Flow Index

43.57

MACD

-3.82

MACD Signal

4.26

Average True Range

152.39

Average Directional Index

13.28

Rate of Change (21)

-1.84

Rate of Change (125)

28.78

Commodity Channel Index

-27.2

Williams %R

-57.4

BETA

1 Month

1.54

3 Month

0.86

1 Year

0.4

3 Year

0.06

PRICE CHANGE ANALYSIS

↑ 1.44%

1 Week

Low

High

6150

6402.2

↓ -1.01%

1 Month

Low

High

6050

6557

↑ 1.45%

3 Months

Low

High

5941.6

6874.45

↑ 31.47%

6 Months

Low

High

4776.8

6874.45

↑ 41.91%

1 Year

Low

High

4365.05

6874.45

Indicator Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Jun 2021 Graph
Total Qtr Revenue cr 1875.80 1931.10 1706.20 1683.60 1694.05 1758.49 1540.21 1439.39 2857.99 2831.49 3003.45
Operating Expenses Qtr 1374.00 1387.40 1270.70 1217.63 1221.86 1262.51 1141.35 1088.68 2421.76 2384.34 2604.12
Operating Profit Qtr 450.30 479.10 417.70 423.20 416.88 453.07 388.34 332.05 424.41 438.86 390.59
EBIDT Qtr Cr 501.80 543.70 435.50 465.97 472.19 495.98 398.86 355.63 436.23 447.15 392.59
Depreciation Qtr 97.20 93.40 93.10 96.69 88.86 91.99 89.15 104.70 97.41 93.73 96.00
Net Profit Qtr 262.80 294.80 214.10 226.86 245.59 279.19 333.14 153.67 175.41 185.89 150.04
Basic EPS Qtr 18.28 20.50 14.89 15.78 17.08 19.42 23.17 10.69 12.20 12.93 10.44
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total Revenue Annual 6676.30 6145.30 9171.10 9805.30 8348.90
Operating Expenses Annual Cr 4843.30 4678.90 8205.70 8379.10 7318.51
Operating Profit Annual 1681.50 1419.40 947.30 1415.30 1018.14
Operating Profit Margin Annual % 25.19 23.10 10.33 14.43 12.19
Total Expenses Annual Cr 5448.80 5286.30 8985.40 9287.30 7886.43
EBIDT Annual Cr 1833.00 1466.40 965.40 1426.20 1030.38
EBIDT Annual margin % 27.46 23.86 10.53 14.55 12.34
Depreciation 366.70 363.40 435.90 482.30 299.89
PAT Before ExtraOrdinary Items Annual Cr 1084.80 572.50 105.00 470.30 302.76
Net Profit Annual 1084.80 665.20 105.00 470.30 302.76
Basic EPS Annual 75.45 46.25 7.50 33.80 21.76
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total ShareHolders Funds Annual 6924.80 6110.70 5201.50 3988.40 3883.42
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 2612.30 3108.30 3006.40 4212.80 2911.85
Total Current Liabilities Annual Cr 1243.30 1189.20 1521.30 1943.00 1633.08
Total Capital Plus Liabilities Annual Cr 10780.40 10408.20 9729.20 10144.20 8428.35
Fixed Assets Annual 5174.40 5144.60 5257.20 6282.30 4788.62
Total Non Current Assets Annual 7629.70 6953.00 6691.50 7829.20 6425.33
Total Current Assets Annual 3150.70 3455.20 3037.70 2315.00 2003.02
Total Assets Annual 10780.40 10408.20 9729.20 10144.20 8428.35
Contingent Liabilities plus Commitments Annual Cr 928.80 863.40 1452.40 868.80 1065.38
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Cash from Operating Activity Annual 1224.50 1201.00 915.40 1096.10 907.27
Cash from Investing Activity Annual -588.50 -444.80 -764.70 -263.90 -775.56
Cash from Financing Annual Activity -778.60 -637.20 -175.40 -770.70 -159.69
Net Cash Flow Annual -142.60 119.00 -24.70 61.50 -27.98
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Book Value Per Share Annual 481.56 424.94 361.72 286.52 279.13
ROE Annual % 15.66 10.88 2.01 11.79 7.79
ROCE Annual % 15.37 11.96 6.45 11.50 10.74
Total Debt to Total Equity Annual 0.25 0.33 0.38 0.74 0.79
EBDIT Annual Margin % 28.09 24.04 10.54 14.56 12.35
Indicator Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Jun 2021 Graph
Total Qtr Revenue cr 4878.40 4869.10 4446.00 4318.55 4298.94 4273.64 3811.66 3577.15 3656.08 3722.70 3784.85
Operating Expenses Qtr 4236.90 4219.40 3908.80 3814.05 3758.23 3685.70 3304.86 3083.19 3051.91 3102.08 3240.34
Operating Profit Qtr 613.70 627.50 509.00 488.15 505.35 565.37 490.74 463.24 587.02 614.99 519.87
EBIDT Qtr Cr 641.50 651.60 537.20 504.50 540.71 587.94 506.80 493.96 604.17 620.62 838.62
Depreciation Qtr 167.00 163.40 166.90 159.06 153.39 155.01 147.78 166.40 148.99 144.76 140.56
Net Profit Qtr 245.30 232.90 166.60 144.52 153.46 203.99 317.11 90.14 228.37 247.82 489.28
Basic EPS Qtr 17.06 16.20 11.59 10.05 10.67 14.19 22.05 6.27 15.88 17.24 34.03
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total Revenue Annual 16702.80 14740.80 10605.00 11273.70 9648.88
Operating Expenses Annual Cr 14562.90 12477.50 9422.60 9659.50 8553.78
Operating Profit Annual 2049.60 2185.10 1137.40 1587.30 1063.66
Operating Profit Margin Annual % 12.27 14.82 10.73 14.08 11.02
Total Expenses Annual Cr 15559.10 13456.80 10444.90 10812.00 9276.32
EBIDT Annual Cr 2139.90 2263.30 1182.40 1614.20 1095.10
EBIDT Annual margin % 12.81 15.35 11.15 14.32 11.35
Depreciation 615.40 600.70 573.10 619.70 395.52
PAT Before ExtraOrdinary Items Annual Cr 887.50 1101.10 136.00 434.80 199.19
Net Profit Annual 819.10 1055.60 150.40 454.80 236.05
Basic EPS Annual 56.97 73.42 10.74 32.70 16.97
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total ShareHolders Funds Annual 6197.40 5623.30 4602.50 3339.10 3333.47
Minority Interest Liability Annual Cr 333.90 254.40 199.90 130.70 135.46
Total Non Current Liabilities Annual Cr 4571.60 4931.40 4576.40 5531.30 3758.76
Total Current Liabilities Annual Cr 3324.90 2383.30 2037.90 2337.30 1955.38
Total Capital Plus Liabilities Annual Cr 14427.80 13192.40 11416.70 11338.40 9183.07
Fixed Assets Annual 8143.90 7391.40 6636.90 7321.50 5457.18
Total Non Current Assets Annual 10090.80 9070.80 7775.50 8691.60 6901.34
Total Current Assets Annual 4337.00 4121.60 3641.20 2646.80 2281.73
Total Assets Annual 14427.80 13192.40 11416.70 11338.40 9183.07
Contingent Liabilities plus Commitments Annual Cr 732.40 658.10 1636.00 651.60 836.01
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Cash from Operating Activity Annual 1376.70 1628.00 1273.40 1292.80 904.95
Cash from Investing Activity Annual -870.60 -778.20 -872.30 -288.80 -710.56
Cash from Financing Annual Activity -633.00 -792.60 -340.10 -909.50 -214.51
Net Cash Flow Annual -126.90 57.20 61.00 94.50 -20.12
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Book Value Per Share Annual 454.19 408.74 333.96 249.27 249.34
ROE Annual % 13.21 18.77 3.26 13.62 7.08
ROCE Annual % 13.73 15.38 6.49 11.04 9.67
Total Debt to Total Equity Annual 0.44 0.47 0.54 1.00 1.03
EBDIT Annual Margin % 12.88 15.43 11.19 14.35 11.38
Name Holding Percent Holding Id Pledged % Locked %
HDFC TRUSTEE COMPANY LIMITED 3.84 74201917 - -
AXIS MUTUAL FUND TRUSTEE LIMITED 1.81 74201918 - -
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED 1.35 74201920 - -
GOVERNMENT OF SINGAPORE 2.14 74201929 - -
GOVERNMENT PENSION FUND GLOBAL 1.28 74201931 - -
Name Holding Percent Holding Id Pledged % Locked %
Ms. Suneeta Reddy 3.36 74201891 48.51 0
Ms. Sangita Reddy 1.69 74201892 0 0
Ms. Shobana Kamineni 1.56 74201893 0 0
Mr. K Vishweshwar Reddy 1.1 74201894 58.01 0
Ms. Preetha Reddy 0.73 74201895 0 0
M/s. PCR Investments Ltd 18.93 74201912 12.95 0
Name Holding Percent Holding Id
HDFC TRUSTEE COMPANY LIMITED 3.84 74201917
AXIS MUTUAL FUND TRUSTEE LIMITED 1.81 74201918
SBI NIFTY 50 ETF 1.5 74201919
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED 1.35 74201920
NIPPON LIFE INDIA TRUSTEE LTD 1.04 74201921
GOVERNMENT OF SINGAPORE 2.14 74201929
SCHRODER INTERNATIONAL SELECTION FUND ASIAN OPPORTUNITIES 1.64 74201930
GOVERNMENT PENSION FUND GLOBAL 1.28 74201931
LIFE INSURANCE CORPORATION OF INDIA 1.58 74201923
Name Holding Percent Holding Id
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Feb 20, 2024 6 INTERIM Feb 20, 2024 Equity Share
Aug 18, 2023 9 FINAL Aug 19, 2023 Equity Share
Feb 24, 2023 6 FINAL Feb 24, 2023 Equity Share
Aug 18, 2022 11.75 FINAL - Equity Share
Aug 18, 2021 3 FINAL - Equity Share
Sep 17, 2020 2.75 FINAL - Equity Share
Feb 25, 2020 3.25 INTERIM Feb 26, 2020 Equity Share
Sep 12, 2019 6 FINAL - Equity Share
Sep 12, 2018 5 FINAL - Equity Share
Sep 07, 2017 6 FINAL - Equity Share
Mar 22, 2016 6 INTERIM Mar 23, 2016 Equity Share
Jul 30, 2015 5.75 FINAL - Equity Share
Aug 13, 2014 5.75 FINAL - Equity Share
Jul 25, 2013 5.5 FINAL - Equity Share
Jul 26, 2012 4 FINAL - Equity Share
Jul 07, 2011 3.75 FINAL - Equity Share
Jul 15, 2010 7 FINAL - Equity Share
Aug 20, 2009 6.5 FINAL - Equity Share
Aug 11, 2008 6 FINAL - Equity Share
Aug 09, 2007 2 FINAL - Equity Share
Mar 22, 2007 3 INTERIM Mar 24, 2007 Equity Share
Jul 27, 2006 4.5 FINAL - Equity Share
Jul 29, 2005 4 FINAL - Equity Share
Aug 30, 2004 3.5 FINAL - Equity Share
Aug 11, 2003 3 FINAL - Equity Share
Sep 02, 2002 - FINAL - Equity Share
Aug 17, 2001 - FINAL - Equity Share
Aug 22, 2000 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Sep 02, 2010 10:5 2010-09-03
Ex-Date Purpose Notes
Feb 08, 2024 Quarterly Results & Interim Dividend -
Nov 09, 2023 Quarterly Results -
Aug 11, 2023 Quarterly Results -
May 30, 2023 Audited Results & Final Dividend -
Feb 14, 2023 Quarterly Results & Interim Dividend -
Nov 30, 2022 Others Inter-alia, to consider and approve the issuance of unsecured Non-Convertible Debentures on private placement basis.
Nov 10, 2022 Quarterly Results -
Aug 11, 2022 Quarterly Results -
May 25, 2022 Audited Results & Dividend -
Feb 11, 2022 Quarterly Results -
Nov 12, 2021 Quarterly Results -
Aug 13, 2021 Quarterly Results -
Jun 23, 2021 Audited Results & Dividend -
Feb 12, 2021 Quarterly Results -
Jan 22, 2021 Others inter alia, consider and determine the issue price of Equity Shares to be issued pursuant to the QlP.
Nov 11, 2020 Quarterly Results -
Sep 14, 2020 Quarterly Results -
Jun 25, 2020 Audited Results (Revised)
Jun 22, 2020 Audited Results -
Feb 13, 2020 Quarterly Results & Interim Dividend -
Nov 14, 2019 Quarterly Results -
Aug 13, 2019 Quarterly Results -
May 30, 2019 Audited Results & Dividend -
Feb 09, 2019 Quarterly Results -
Nov 14, 2018 Quarterly Results -
Aug 10, 2018 Quarterly Results -
May 30, 2018 Audited Results & Dividend -
Feb 14, 2018 Quarterly Results -
Nov 13, 2017 Quarterly Results -
Aug 14, 2017 Quarterly Results -
May 30, 2017 Audited Results & Dividend -
Feb 14, 2017 Quarterly Results & Others -
Nov 11, 2016 Quarterly Results -
Oct 07, 2016 Others Allotment of 3000 secured Redeemable Non-Convertible Debentures of face value of Rs. 10 lakhs each aggregating to Rs. 300 crores to Institutional Investors/Banks/Financial Institutions.
Oct 04, 2016 Others Approve the issue of rated, listed, secured Redeemable Non-Convertible Debentures on a private placement basis to be listed on the wholesale debt market segment of the National Stock Exchange.
Sep 01, 2016 Quarterly Results -
May 25, 2016 Audited Results The Board of Directors considered and confirmed the interim dividend declared at its meeting held on March 15, 2016 and paid to the shareholders on March 29, 2016.
Mar 15, 2016 Interim Dividend -
Feb 12, 2016 Quarterly Results -
Nov 14, 2015 Quarterly Results -
Aug 11, 2015 Quarterly Results -
May 28, 2015 Audited Results & Dividend Proposal for further issue of equity shares on a Rights basis, to the existing shareholders of the Company.
Feb 14, 2015 Quarterly Results -
Nov 12, 2014 Quarterly Results -
Aug 12, 2014 Quarterly Results -
May 28, 2014 Audited Results & Dividend -
Feb 10, 2014 Quarterly Results -
Nov 12, 2013 Quarterly Results -
Aug 07, 2013 Quarterly Results -
May 20, 2013 Audited Results & Dividend -
Feb 07, 2013 Quarterly Results -
Nov 09, 2012 Quarterly Results -
Aug 10, 2012 Quarterly Results -
May 29, 2012 Audited Results & Dividend -
Feb 10, 2012 Quarterly Results -
Nov 04, 2011 Quarterly Results -
Aug 10, 2011 Quarterly Results -
May 24, 2011 Audited Results & Dividend -
Feb 11, 2011 Quarterly Results -
Dec 09, 2010 Allotment of Equity Shares For allotment of 1,140,992 Equity Shares to the International Finance Corporation, Washington DC at a price of Rs. 302.50 per Equity Share of Rs. 5/- each upon part conversion of FCCB loan amount.
Nov 09, 2010 Quarterly Results -
Aug 12, 2010 Quarterly Results & Others To determine the eligible Shareholders of the Company, to receive the sub-divided Equity Shares of face value of Rs. 5/- each in the place of existing Equity Shares of face value of Rs. 10/- each.
May 28, 2010 Stock split The Board has approved the sub-division of each existing Equity Share of nominal value of Rs. 10/- each into 2 Equity Shares of nominal value of Rs. 5/- each, subject to approval of members.
Apr 30, 2010 Issue of Convetible Warrants To issue upto 1,544,621 Warrants Conv. into Equity Shares to Dr. Prathap C. Reddy, with each Warrant Conv. into one Equity Share of the Co. of NV of Rs. 10/- each at a price of Rs. 771.76 per Share.
Jan 28, 2010 Quarterly Results & Others For allotment of 1500 Unsecured Foreign Currency Convertible Bonds of face value of USD 10,000 each aggregating to USD 15 million to International Finance Corporation, Washington.
Oct 29, 2009 Quarterly Results -
Jul 18, 2009 Quarterly Results -
Jun 29, 2009 Audited Results, Dividend & Others To issue of FCCB' s, subject to regarding approvals being obtained, including approval of the members of the Co. for a value up to USD 15,000,000 to International Finance Corporation ("IFC").
Jan 30, 2009 Quarterly Results -
Oct 30, 2008 Quarterly Results & Stock Split inter alia, to drope the proposal of sub-division of each existing equity share of Rs 10/- each into 10 (Ten) equity shares of Re 1/- each.
Jul 31, 2008 Quarterly Results -
Jun 24, 2008 Audited Results & Dividend -
Jan 24, 2008 Quarterly Results -
Oct 23, 2007 Quarterly Results -
Jul 23, 2007 Quarterly Results -
Jun 26, 2007 Audited Results & Final Dividend -
Mar 16, 2007 Interim Dividend -
Jan 24, 2007 Quarterly & Half Yearly Results -
Jan 05, 2007 To consider issue of Warrants To issue up to 1,550,000 warrants convertible into equity shares of Rs 10/- each on preferential allotment basis to Ms. Sangita Reddy.
Nov 22, 2006 Half Yearly Results -
Jul 25, 2006 Quarterly Results -
Jun 12, 2006 Accounts & Dividend -
May 12, 2006 To raise long term resources -
Jan 30, 2006 Quarterly Results -
Dec 12, 2005 Proposal to acquire new hospital To consider interalia the proposal to acquire new hospital.
Nov 25, 2005 Half Yearly Results -
Nov 04, 2005 Others To consider a proposal to purchase 100% of equity capital of Samudra Healthcare Enterprises Ltd, Kakinanda, Andhra Pradesh, an unlisted public limited Company.
Jul 25, 2005 Quarterly Results -
Jun 03, 2005 Allotment of share warrants The Board has approved the allotment of 1,039,965 Share Warrants to the specified promoters convertible into Equity Shares within 18 months from the date of allotment i.e. December 02, 2006.
May 23, 2005 Accounts & Dividend -
Apr 18, 2005 Preferential issue of warrants 1. Further issue of Equity Shares / Depository Receipts / Convertible Shares Warrants / FCCB on preferential basis. 2. Preferential issue of warrants & equity shares.
Jan 18, 2005 Quarterly Results -
Nov 16, 2004 Half Yearly Results -
Jul 30, 2004 Others Issue of equity shares up to a maximum of 5% of paid up capital on private placement basis.
Jun 25, 2004 Dividend & Accounts -
Jan 22, 2004 Quarterly Results -
Jul 21, 2003 Quarterly Results -
Jun 25, 2003 Accounts & Dividend -
Jan 28, 2003 Quarterly Results -
Nov 28, 2002 Half Yearly Results -
Jul 30, 2002 Quarterly Results -
Jun 17, 2002 Accounts & Dividend -
Mar 04, 2002 Interim Dividend -
Jan 23, 2002 Quarterly Results -
Nov 30, 2001 Half Yearly Results (Revised)
Oct 27, 2001 Scheme of Demerger Scheme of Demerger of Clinic Division run by Apollo Mumbai Hospital Ltd. into the company
Jul 31, 2001 Quarterly Results -
Jun 11, 2001 Accounts -
Jan 25, 2001 Quarterly Results -
Oct 22, 2000 Quarterly Results -
Jul 31, 2000 Quarterly Results -
Jun 28, 2000 Accounts -
Jan 31, 2000 Quarterly Results -
Dec 15, 1999 Amalgamation & Merger Amalgamation of Deccan Hospital Corp.Ltd. with the Co. & Preferential Offer
Oct 28, 1999 Quarterly Results -
Jul 15, 1999 Quarterly Results -
Jun 16, 1999 Accounts -
Jan 30, 1999 Quarterly Results -
Jul 29, 1998 Quarterly Results -
Jun 20, 1998 Accounts -
Jun 25, 1997 Accounts. -
Ex-Date Bonus Ratio Record Date
Bigul
27 Apr 2024

APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Reg.40(10) - PCS Certificate For Transfer / Transmission / Transposition

 Reg.40(10) - PCS Certificate for Transfer / Transmission / Transposition is enclosed
26 Apr 2024

Apollo HealthCo Secures Rs 2,475 Crore Investment From Advent International In Major Deal

 Apollo HealthCo Ltd, a subsidiary of Apollo Hospitals Enterprise Ltd, secures Rs 2,475 crore investment from Advent International, forming a joint entity valued at Rs 22,481 crore.
Bigul
26 Apr 2024

APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Subject: Disclosure under Regulation 30 the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - revised Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a conference call for the analysts/investors is scheduled to be held on Saturday, 27th April 2024 at 1.30 p.m. regarding update on Apollo Healthco transaction. Pl. find enclosed the details of conference call (revised) for your reference.
Bigul
26 Apr 2024

APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Announcement under Regulation 30 (LODR)-Investor Presentation

 As per annexure enclosed
Bigul
26 Apr 2024

APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 As per annexure enclosed
Bigul
26 Apr 2024

APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 As per annexure enclosed
Bigul
26 Apr 2024

APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Board Meeting Outcome for Disclosure Pursuant To Regulations 30 And 30A Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 As Amended ('LODR') Read With SEBI Circular SEBI/HO/CFD/CFD-Pod-1/P/CIR/2023/123 Dated July 13, 2023

 As per annexure enclosed
Bigul
25 Apr 2024

APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Annexure enclosed
Bigul
16 Apr 2024

APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Annexure enclosed
Bigul
06 Apr 2024

APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Sub: Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Submission Of Proceedings Of Annual General Meeting Of The Company Held On 30Th August 2023. Ref : Your Mail Dated 6Th April 2024

 Response to your mail dated 6th April 2024 as per annexure enclosed
See all News

FAQs

The latest market price of Apollo Hospitals Enterprise Ltd. on NSE was Rs. 6258.60 as of today.

The opening share price of Apollo Hospitals Enterprise Ltd. was Rs. 6380.00 as of today.

The 52-week high share price of Apollo Hospitals Enterprise Ltd. was Rs. 6874.40.

The 52 week low share price of Apollo Hospitals Enterprise Ltd. was Rs. 4365.00.

Apollo Hospitals Enterprise Ltd. has a market cap of Rs. 89989.10 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Apollo Hospitals Enterprise Ltd. is 35.40. Please refer to the Fundamentals section for further details.

The operating revenue for Apollo Hospitals Enterprise Ltd. in the last FY was Rs.  18417.50 crore. Please refer to the Financials section for further details.

The Net Profit for Apollo Hospitals Enterprise Ltd. in the last FY was Rs. 789.32 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Apollo Hospitals Enterprise Ltd. was on 2024-02-20 for Rs. 6 per share. According to today’s share price, the dividend yield of Apollo Hospitals Enterprise Ltd. stands at 0.20. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

The latest split issue declared by Apollo Hospitals Enterprise Ltd. was as of 2010-09-02. The split ratio declared in this issue was 10:5. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Apollo Hospitals Enterprise Ltd..

Close

Let's Open Free Demat Account